A mathematical model to predict short-term recurrence and metastasis of primary hepatocellula carcinoma larger than 10cm in diameter

Hepato-Gastroenterology

Volumn 60, Issue 121, 2013, Pages 225-230

  Huang, Xinhui ^a   Wei, Wei ^a   Ya, Na ^a   Zeng, Jinhua ^a   Zeng, Yongyi ^a   Ma, Chuang ^a   Chi, Minhui ^a   Wu, Yanbin ^a   Li, Yuntong ^a   Huang, Yao ^a   Zhang, Xiang ^a   Huang, Aimin ^a   Liu, Jingfeng ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Early Stage; Huge hepatocellular carcinoma; Metastasis; Prediction.; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METASTASIS; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; TUMOR THROMBUS; TUMOR VOLUME;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; TIME FACTORS;

EID: 84877701495     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12630     Document Type: Article

References (37)

1. Kim JH, Choi MS, Lee H, et al.: Clinical features and prognosis of hepatocellular carcinoma in young patients from a hepatitis B-endemic area. J Gastroenterol Hepatol 2006; 21:588-594.
2. Lam VW, Ng KK, Chok KS, et al.: Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma. J Am Coll Surg 2008; 207:20-29.
3. Lau WY, Lai EC: Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 2008; 7:237-257.
4. Llovet JM, Fuster J, Bruix J: Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30:1434-1440.
5. Tsim NC, Frampton AE, Habib NA, et al.: Surgical treatment for liver cancer. World J Gastroenterol 2010; 16:927-933.
6. Ercolani G, Grazi GL, Ravaioli M, et al.: Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 2003; 237:536-543. (Pubitemid 38176435)
7. Lee SG, Hwang S, Jung JP, et al.: Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions. Brit J Surg 2007; 94:320-326. (Pubitemid 46423850)
8. Poon RT, Fan ST, Wong J: Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10cm in diameter. J Am Coll Surg 2002; 194:592-602. (Pubitemid 34496654)
9. Pandey D, Lee KH, Wai CT, et al.: Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 2007; 14:2817-2823. (Pubitemid 47460658)
10. Yeh CN, Lee WC, Chen MF: Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol 2003; 10:1070-1076.
11. Iizuka N, Oka M, Yamada-Okabe H, et al.: Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 2003; 361:923-929. (Pubitemid 36332108)
12. Livraghi T, Giorgio A, Marin G, et al.: Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
13. Harada T, Matsuo K, Inoue T, et al.: Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996; 224:4-9. (Pubitemid 26227401)
14. Chen XP, Qiu FZ, Wu ZD, et al.: Hepatectomy for huge hepatocellular carcinoma in 634 cases. World J Gastroenterol 2006; 12:4652-4655.
15. Pawlik TM, Poon RT, Abdalla EK, et al.: Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 2005; 140:450-457; discussion 57-58.
16. Liau KH, Ruo L, Shia J, et al.: Outcome of partial hepatectomy for large (>10cm) hepatocellular carcinoma. Cancer 2005; 104:1948-1955. (Pubitemid 41513179)
17. Bennett JJ, Blumgart LH: Assessment of hepatic reserve prior to hepatic resection. J Hepato-biliary-pancreatic Surg 2005; 12:10-15. (Pubitemid 40378834)
18. Gazzaniga GM, Cappato S, Belli FE, et al.: Assessment of hepatic reserve for the indication of hepatic resection: how I do it. J hepato-biliary- pancreatic surgery 2005; 12:27-30.
19. Cho YB, Lee KU, Lee HW, et al.: Outcomes of hepatic resection for a single large hepatocellular carcinoma. World J Surg 2007; 31:795-801. (Pubitemid 46496216)
20. Li YM, Lv F, Xu X, et al.: Evaluation of liver functional reserve by combining D-sorbitol clearance rate and CT measured liver volume. World J Gastroenterol 2003; 9:2092-2095. (Pubitemid 37168450)
21. Abdalla EK, Denys A, Chevalier P, et al.: Total and segmental liver volume variations: implications for liver surgery. Surgery 2004; 135:404-410. (Pubitemid 38453495)
22. Shah SA, Greig PD, Gallinger S, et al.: Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg 2006; 202:275-283. (Pubitemid 43112487)
23. Ibrahim S, Roychowdhury A, Hean TK: Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Am J Surg 2007; 194:17-22. (Pubitemid 46881151)
24. Ng IO, Guan XY, Poon RT, et al.: Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis. J Pathol 2003; 199:345-453.
25. Shah SA, Wei AC, Cleary SP, et al.: Prognosis and results after resection of very large (≥10cm) hepatocellular carcinoma. J Gastrointest Surg 2007; 11:589-595.
26. Poon RT, Fan ST, Ng IO, et al.: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer 2000; 89:500-507. (Pubitemid 30640096)
27. Imamura H, Matsuyama Y, Tanaka E, et al.: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 2003; 38:200-207. (Pubitemid 36169630)
28. Capussotti L, Muratore A, Amisano M, et al.: Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival-a European single center experience. Eur J Surg Oncol 2005; 31:986-993. (Pubitemid 41671112)
29. Dupont-Bierre E, Compagnon P, Raoul JL, et al.: Resection of hepatocellular carcinoma in non-cirrhotic liver: analysis of risk factors for survival. J Am Coll Surg 2005; 201:663-670. (Pubitemid 41539757)
30. Tangkijvanich P, Anukulkarnkusol N, Suwangool P, et al.: Clinical characteristics and prognosis of hepatocellular carcinoma: analysis based on serum alpha-fetoprotein levels. J Clin Gastroenterol 2000; 31:302-308.
31. Johnson PJ: The role of serum alpha-fetoprotein estimation in the diagnosis and management of hepatocellular carcinoma. Clinics in liver disease 2001; 5:145-159.
32. Murgita RA, Goidl EA, Kontianen S, et al.: Alpha-Feto-protein induces suppressor T-cells in vitro. Nature 1977; 267:257-259. (Pubitemid 8095599)
33. Yachnin S, Soltani K, Lester EP: Further studies on the mechanism of suppression of human lymphocyte transformation by human alpha fetoprotein. J Allergy Clin Immunol 1980; 65:127-135. (Pubitemid 10131162)
34. Hanazaki K, Kajikawa S, Koide N, et al.: Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis. Am J Gastroenterol 2001; 96:1243-1250. (Pubitemid 32319168)
35. Sumie S, Kuromatsu R, Okuda K, et al.: Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15:1375-1382.
36. Shirabe K, Wakiyama S, Gion T, et al.: Clinicopathological risk factors linked to recurrence pattern after curative hepatic resection for hepatocellular carcinoma-results of 152 resected cases. Hepato-gastroenterol 2007; 54:2084-2087.
37. Shu H, Kang X, Guo K, et al.: Diagnostic value of serum haptoglobin protein as hepatocellular carcinoma candidate marker complementary to alpha fetoprotein. Oncology reports 2010; 24:1271-1276.